Allowing Medicare to cover anti-obesity medications would drive up federal spending by about $35 billion on net between 2026 and 2034, according to ...
New-generation anti-obesitydrug Wegovy, made by the same company that created Ozempic, is now available in France – but it will not be funded by the French social security system. Danish ...